Jacobs Levy Equity Management’s Achillion Pharmaceuticals, Inc. ACHN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-36,500
| Closed | -$98K | – | 1048 |
|
|
2019
Q2 | $98K | Sell |
36,500
-280,595
| -88% | -$753K | ﹤0.01% | 919 |
|
|
2019
Q1 | $939K | Buy |
317,095
+49,482
| +18% | +$147K | 0.01% | 675 |
|
|
2018
Q4 | $426K | Buy |
267,613
+36,500
| +16% | +$58.1K | 0.01% | 761 |
|
|
2018
Q3 | $850K | Buy |
231,113
+17,300
| +8% | +$63.6K | 0.01% | 674 |
|
|
2018
Q2 | $605K | Buy |
213,813
+62,413
| +41% | +$177K | 0.01% | 762 |
|
|
2018
Q1 | $562K | Sell |
151,400
-4,500
| -3% | -$16.7K | 0.01% | 761 |
|
|
2017
Q4 | $449K | Buy |
+155,900
| New | +$449K | 0.01% | 775 |
|